Docoh
Loading...
Sign up Log in

SYK Stryker

Stryker is one of the world's leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.

Company profile

Ticker
SYK
Exchange
NYSE
Website
www.stryker.com
CEO
Kevin Lobo
Employees
Incorporated
Michigan
Location
Michigan
Fiscal year end
Dec 31
Sector
Manufacturing > Surgical and Medical Instrument Manufacturing
Industry (SIC)
Surgical & Medical Instruments & Apparatus
3M • Boston Scientific • Baxter International • Becton, Dickinson And • Teleflex • Resmed • Hill-Rom • Nuvasive • Integra Lifesciences • Orthofix Medical ...
SEC CIK
0000310764
Corporate docs
IRS number
381239739

SYK stock data

(
)

News

Pro users get this 30m faster
Analyzing Stryker's Unusual Options Activity
30 Jul 21
On Friday, shares of Stryker (NYSE:SYK) saw unusual options activity. After the option alert, the stock price moved up to $270.9.
What 12 Analyst Ratings Have To Say About Stryker
29 Jul 21
Within the last quarter, Stryker (NYSE:SYK) has observed the following analyst ratings: Last 30 Days 1 Month Ago 2 Months Ago
Canaccord Genuity Maintains Buy on Stryker, Raises Price Target to $290
28 Jul 21
Canaccord Genuity analyst Kyle Rose maintains Stryker (NYSE:SYK) with a Buy and raises the price target from $285 to $290.
Stocks That Hit 52-Week Highs On Wednesday
28 Jul 21
Benzinga's Top Ratings Upgrades, Downgrades For July 28, 2021
28 Jul 21

Press releases

Pro users get this 30m faster
Stryker reports second quarter 2021 operating results
27 Jul 21
Kalamazoo, Michigan, July 27, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the second quarter of 2021: Second Quarter Results Reported net sales increased
Stryker to host conference call on July 27, 2021
24 Jun 21
Kalamazoo, Michigan, June 24, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Tuesday, July 27, 2021 at 4:30 p.m., Eastern Time, to discuss the Company's operating

Calendar

28 Jul 21
4 Aug 21
31 Dec 21

Financial summary

Financial statements Chart SYK financial data
Quarter (USD)
 Jun 21 Mar 21 Dec 20 Sep 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
 Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from Stryker earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 2.24B 2.24B 2.24B 2.24B 2.24B 2.24B
Cash burn (monthly) (positive/no burn) 358.17M (positive/no burn) (positive/no burn) (positive/no burn) (positive/no burn)
Cash used (since last report) n/a 419.17M n/a n/a n/a n/a
Cash remaining n/a 1.82B n/a n/a n/a n/a
Runway (months of cash) n/a 5.1 n/a n/a n/a n/a

Beta Read what these cash burn values mean

Recent insider trades

SYK insider ownership history Insider history
Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
1 Aug 21 Scannell Timothy J Common Stock Payment of exercise Dispose F No No 270.94 1,872 507.2K 219,707
1 Aug 21 Scannell Timothy J Common Stock Option exercise Aquire M No No 0 3,659 0 221,579
1 Aug 21 Scannell Timothy J RSU Common Stock Option exercise Dispose M No No 0 3,659 0 0
5 May 21 Srikant M. Datar Common Stock Option exercise Aquire M No No 0 991 0 991
5 May 21 Srikant M. Datar RSU Common Stock Option exercise Dispose M No No 0 991 0 0
5 May 21 Brainerd Mary K Common Stock Option exercise Aquire M No No 0 991 0 3,576
5 May 21 Brainerd Mary K RSU Common Stock Option exercise Dispose M No No 0 991 0 0
5 May 21 Doliveux Roch Common Stock Payment of exercise Dispose F No No 255.59 24 6.13K 23,037
5 May 21 Doliveux Roch Common Stock Option exercise Aquire M No No 0 991 0 23,061
5 May 21 Doliveux Roch RSU Common Stock Option exercise Dispose M No No 0 991 0 0
Data from 3, 4 and 5 filings. Stock values as filed, not updated for current price.

Institutional ownership Q1 2021

SYK institutional ownership history Ownership history

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

70.5% owned by funds/institutions
13F holders
 Current Prev Q Change
Total holders 1484 1477 +0.5%
Opened positions 109 195 -44.1%
Closed positions 102 89 +14.6%
Increased positions 554 513 +8.0%
Reduced positions 551 520 +6.0%
13F shares
 Current Prev Q Change
Total value 64.62B 65.6B -1.5%
Total shares 265.52M 267.95M -0.9%
Total puts 997.53K 1.17M -14.7%
Total calls 891.13K 1.29M -30.7%
Total put/call ratio 1.1 0.9 +23.1%
Largest owners
 Shares Value Change
Vanguard 28.14M $6.85B -1.2%
TROW T. Rowe Price 27.82M $6.78B -6.9%
BLK Blackrock 24.61M $5.99B -2.7%
Greenleaf Trust 20.34M $4.95B -2.3%
STT State Street 12.96M $3.16B -2.7%
Capital Research Global Investors 9.49M $2.31B +13.3%
BK Bank Of New York Mellon 7.39M $1.8B +0.8%
Wellington Management 6.19M $1.51B +90.9%
BEN Franklin Resources 5.65M $1.38B -0.9%
Massachusetts Financial Services 5.07M $1.23B -5.0%
Largest transactions
 Shares Bought/sold Change
Norges Bank 0 -3.31M EXIT
Wellington Management 6.19M +2.95M +90.9%
TROW T. Rowe Price 27.82M -2.07M -6.9%
Capital Research Global Investors 9.49M +1.11M +13.3%
BLK Blackrock 24.61M -670.42K -2.7%
BlueSpruce Investments 1.14M -636.02K -35.7%
AMP Ameriprise Financial 1.76M +582.54K +49.4%
MKFCF Mackenzie Financial 2.07M +516.13K +33.2%
Greenleaf Trust 20.34M -476.85K -2.3%
FMR 4.61M +420.38K +10.0%
Data from 13F filings. Stock values as filed, not updated for current price. Long positions only.

Financial report summary

?
Competition
Fuse Medical • Axogen • Smith & Nephew • Merit Medical Systems • Misonix • Orthofix Medical • Anika Therapeutics • Gentherm • Integra Lifesciences • Zimmer Biomet
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Good
New words: administered, apply, behalf, bid, bidder, certification, charge, clear, Department, disciplined, eased, encryption, facilitate, Federal, Federation, free, frequency, FSB, geography, issuer, knowingly, license, licensing, loan, long, nationwide, notification, OFAC, permitted, permitting, plant, preparation, prohibited, province, provincial, qualify, radio, ramp, region, regional, revenue, Russia, Russian, sanctionable, Service, subsequent, successor, Treasury, unsuccessful, VBP
Removed: April, contact, corporate, decrease, health, postponement, receivable, social, spread, unfavorable
From filing 10-Q 2021 Q2

Financial reports

View all
10-Q
2021 Q2
Quarterly report
28 Jul 21
10-Q
2021 Q1
Quarterly report
28 Apr 21
10-K
2020 FY
Annual report
11 Feb 21
10-Q
2020 Q3
Quarterly report
30 Oct 20
10-Q
2020 Q2
Quarterly report
31 Jul 20
10-Q
2020 Q1
Quarterly report
1 May 20
10-K
2019 FY
Annual report
6 Feb 20
10-Q
2019 Q3
Quarterly report
30 Oct 19
10-Q
2019 Q2
Quarterly report
26 Jul 19
10-Q
2019 Q1
Quarterly report
24 Apr 19

Current reports

View all
8-K
Stryker Reports Second Quarter 2021 Operating Results
27 Jul 21
8-K
Submission of Matters to a Vote of Security Holders
11 May 21
8-K
Stryker Reports First Quarter 2021 Operating Results
27 Apr 21
8-K
Departure of Directors or Certain Officers
5 Feb 21
8-K
Stryker Reports 2020 Operating Results and 2021 Outlook
27 Jan 21
8-K
Entry into a Material Definitive Agreement
23 Nov 20
8-K
Completion of Acquisition or Disposition of Assets
16 Nov 20
8-K
Entry into a Material Definitive Agreement
13 Nov 20
8-K
Departure of Directors or Certain Officers
9 Nov 20
8-K
Stryker Reports Third Quarter 2020 Operating Results
29 Oct 20

Registration and prospectus

View all
25-NSE
Exchange delisting
30 Nov 20
424B5
Prospectus supplement for primary offering
20 Nov 20
FWP
Free writing prospectus
18 Nov 20
424B5
Prospectus supplement for primary offering
18 Nov 20
SC TO-T/A
Third party tender offer statement (amended)
12 Nov 20
SC TO-T/A
Third party tender offer statement (amended)
4 Nov 20
SC TO-T/A
Third party tender offer statement (amended)
26 Oct 20
SC TO-T/A
Third party tender offer statement (amended)
21 Oct 20
SC TO-T/A
Third party tender offer statement (amended)
15 Oct 20
SC TO-T/A
Third party tender offer statement (amended)
14 Oct 20

Proxies

View all
DEFA14A
Additional proxy soliciting materials
24 Mar 21
DEF 14A
Definitive proxy
24 Mar 21
DEFA14A
Additional proxy soliciting materials
24 Mar 20
DEF 14A
Definitive proxy
24 Mar 20
DEFA14A
Additional proxy soliciting materials
18 Nov 19
DEFA14A
Additional proxy soliciting materials
6 Nov 19
DEFA14A
Additional proxy soliciting materials
6 Nov 19
DEFA14A
Additional proxy soliciting materials
4 Nov 19
DEFA14A
Additional proxy soliciting materials
20 Mar 19
DEF 14A
Definitive proxy
20 Mar 19

Other

View all
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
28 Jul 21
SD
Conflict minerals disclosure
28 May 21
SD
Conflict minerals disclosure
29 May 20
SD
Conflict minerals disclosure
31 May 19
SD
Conflict minerals disclosure
31 May 18
SD
Conflict minerals disclosure
30 May 17
SD
Conflict minerals disclosure
30 May 16
SD
Conflict minerals disclosure
31 May 15
SD
Conflict minerals disclosure
1 Jun 14
UPLOAD
Letter from SEC
12 Dec 13

Ownership

View all
4
STRYKER / Timothy J Scannell ownership change
3 Aug 21
4
STRYKER / RONDA E STRYKER ownership change
7 May 21
4
STRYKER / Rajeev Suri ownership change
7 May 21
4
STRYKER / Andrew K Silvernail ownership change
7 May 21
4
STRYKER / Sherilyn S McCoy ownership change
7 May 21
4
STRYKER / Allan C. Golston ownership change
7 May 21
4
STRYKER / Srikant M. Datar ownership change
7 May 21
4
STRYKER / Giovanni Caforio ownership change
7 May 21
4
STRYKER / MARY K BRAINERD ownership change
7 May 21
4
STRYKER / Rajeev Suri ownership change
7 May 21

Patents

View all
GRANT
Design
Spinal fastener with serrated thread
3 Aug 21
Inventors: Erika Corbin, Lori Dombrowski, Charles L. Bush, Jr., Paul R. Rochette
GRANT
Utility
Knotless filament anchor for soft tissue repair
3 Aug 21
In one embodiment, the present invention includes a method for securing tissue to bone, including drilling a bone hole into the bone; passing a filament through the tissue, the filament including a first end, a second end and a length therebetween, the second end having a loop; passing the first end of the filament through the loop of the filament; pulling on the first end of the filament such that the loop travels along the length of the filament and to the tissue; passing an anchor along the length of the filament, from the first end towards the loop and tissue; engaging the loop with a distal end of the anchor; positioning the distal end of the anchor, with the loop of the filament, into the bone hole; and securing the anchor in the bone.
GRANT
Utility
Navigated surgical system including override option
3 Aug 21
A surgical system including a surgical tool and a navigation system for tracking the position of the surgical tool.
GRANT
Utility
Patient specific humeral cutting guides
3 Aug 21
A humeral guide is provided that has a first portion or member configured to be positioned on a portion of a proximal humerus.
GRANT
Utility
Robotically-assisted constraint mechanism
3 Aug 21
A surgical system includes a robotic arm, a constraint mechanism coupled to the robotic arm, and a computer system configured to control the robotic arm to constrain manual movement of the constraint mechanism to a plane.

Transcripts

View all
2021 Q2
Earnings call transcript
28 Jul 21
2021 Q1
Earnings call transcript
28 Apr 21
2020 Q4
Earnings call transcript
28 Jan 21
2020 Q3
Earnings call transcript
29 Oct 20
2020 Q2
Earnings call transcript
30 Jul 20
2020 Q1
Earnings call transcript
30 Apr 20
2019 Q4
Earnings call transcript
29 Jan 20
2019 Q3
Earnings call transcript
29 Oct 19
2019 Q2
Earnings call transcript
25 Jul 19
2019 Q1
Earnings call transcript
23 Apr 19

Reddit threads

View all